<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>To determine whether leptin receptor (LEPR) 223A&gt;G polymorphism has an effect on the plasma leptin levels and the macroangiopathic complications in type 2 <z:hpo ids='HP_0000819'>diabetes mellitus</z:hpo> (T2DM) </plain></SENT>
<SENT sid="1" pm="."><plain>The genotypes and allelic frequencies of the LEPR 223A&gt;G were examined with polymerase chain reaction and restriction fragment length polymorphism in 301 patients with T2DM and 172 unrelated healthy subjects </plain></SENT>
<SENT sid="2" pm="."><plain>The plasma concentrations of leptin were determined in <z:hpo ids='HP_0000001'>all</z:hpo> subjects </plain></SENT>
<SENT sid="3" pm="."><plain>The mean plasma leptin levels in the T2DM group were significantly higher than that of controls and the plasma levels of leptin were higher in diabetic patients with <z:e sem="disease" ids="C1096293" disease_type="Disease or Syndrome" abbrv="">macroangiopathy</z:e> than in patients without <z:e sem="disease" ids="C1096293" disease_type="Disease or Syndrome" abbrv="">macroangiopathy</z:e> (P &lt; 0.05) </plain></SENT>
<SENT sid="4" pm="."><plain>The genotype (GG, AG and AA) distribution of 223A&gt;G polymorphism was 58.3, 32.5, and 9.2% in diabetic patients with <z:e sem="disease" ids="C1096293" disease_type="Disease or Syndrome" abbrv="">macroangiopathy</z:e>, 75.3, 22.1, and 2.6% in patients without <z:e sem="disease" ids="C1096293" disease_type="Disease or Syndrome" abbrv="">macroangiopathy</z:e>, and 70.3, 27.5, 2.2% in controls respectively, a significant difference was found between diabetic patients with and without <z:e sem="disease" ids="C1096293" disease_type="Disease or Syndrome" abbrv="">macroangiopathy</z:e> (P &lt; 0.05) </plain></SENT>
<SENT sid="5" pm="."><plain>The frequency of the allele A was higher in patients with <z:e sem="disease" ids="C1096293" disease_type="Disease or Syndrome" abbrv="">macroangiopathy</z:e> than in patients without <z:e sem="disease" ids="C1096293" disease_type="Disease or Syndrome" abbrv="">macroangiopathy</z:e> (25.6 vs. 16.3%; P &lt; 0.05) </plain></SENT>
<SENT sid="6" pm="."><plain>Moreover, the plasma leptin levels were markedly higher in patients with AA genotype than those with AG or GG genotype in patients with <z:e sem="disease" ids="C1096293" disease_type="Disease or Syndrome" abbrv="">macroangiopathy</z:e> (P &lt; 0.05) </plain></SENT>
<SENT sid="7" pm="."><plain>The LEPR 223A&gt;G gene polymorphism associated with a predisposition to increased plasma leptin levels could constitute a useful predictive marker for <z:e sem="disease" ids="C1504375" disease_type="Disease or Syndrome" abbrv="">diabetic macroangiopathy</z:e> </plain></SENT>
</text></document>